v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Product sales, net $ 15,705 $ 16,004
Cost of goods sold 8,537 8,919
Gross profit 7,168 7,085
Operating expenses:    
Research and development 118 151
Selling, general and administrative 9,240 9,745
Benefit from reversal of accrued payroll taxes (Note 12) 0 (6,171)
Total operating expenses 9,358 3,725
Operating income (loss) (2,190) 3,360
Other expense, net 212 264
Income (loss) before income taxes (2,402) 3,096
Income tax benefit (8) (6)
Net income (loss) $ (2,394) $ 3,102
Weighted average common shares outstanding    
Basic 175,585 153,954
Diluted 175,585 153,955
Net income (loss) per share    
Basic $ (0.01) $ 0.02
Diluted $ (0.01) $ 0.02

Source